Kevin A.  Lobo net worth and biography

Kevin Lobo Biography and Net Worth

CEO of Stryker
Kevin A. Lobo has been CEO of Stryker since October 1, 2012, and also assumed the role of Chair of the Board on July 22, 2014. He joined Stryker in 2011 and had previously been Group President of Orthopaedics.

Mr. Lobo serves on the board of directors for Parker Hannifin Corporation (NYSE:PH) and the U.S.-India Business Council. He is also a member of the Business Roundtable and Business Council. Mr. Lobo recently served as chairman of the Advanced Medical Technology Association (AdvaMed) Board of Directors.

Mr. Lobo has a broad business career across multiple industries. After holding finance positions with KPMG, Unilever and Kraft Canada, he spent eight years with Rhone-Poulenc, including roles based in Europe as Corporate Controller of a chemical spin-out and General Manager of Specialty Phosphates EMEA. He then spent eight years at Johnson & Johnson, including President of Ethicon Endo Surgery.

What is Kevin A. Lobo's net worth?

The estimated net worth of Kevin A. Lobo is at least $27.45 million as of November 17th, 2023. Mr. Lobo owns 81,034 shares of Stryker stock worth more than $27,451,078 as of April 16th. This net worth evaluation does not reflect any other investments that Mr. Lobo may own. Additionally, Mr. Lobo receives a salary of $5,700,000.00 as CEO at Stryker. Learn More about Kevin A. Lobo's net worth.

How old is Kevin A. Lobo?

Mr. Lobo is currently 59 years old. There are 6 older executives and no younger executives at Stryker. Learn More on Kevin A. Lobo's age.

What is Kevin A. Lobo's salary?

As the CEO of Stryker Co., Mr. Lobo earns $5,700,000.00 per year. Learn More on Kevin A. Lobo's salary.

How do I contact Kevin A. Lobo?

The corporate mailing address for Mr. Lobo and other Stryker executives is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. Stryker can also be reached via phone at (269) 385-2600 and via email at [email protected]. Learn More on Kevin A. Lobo's contact information.

Has Kevin A. Lobo been buying or selling shares of Stryker?

Kevin A. Lobo has not been actively trading shares of Stryker within the last three months. Most recently, Kevin Lobo sold 56,483 shares of the business's stock in a transaction on Friday, November 17th. The shares were sold at an average price of $287.91, for a transaction totalling $16,262,020.53. Following the completion of the sale, the chief executive officer now directly owns 81,034 shares of the company's stock, valued at $23,330,498.94. Learn More on Kevin A. Lobo's trading history.

Who are Stryker's active insiders?

Stryker's insider roster includes Yin Becker (VP), William Berry, Jr. (VP), Glenn Boehnlein (CFO), Srikant Datar (Director), Roch Doliveux (Director), M. Fink (VP), Robert Fletcher (VP), Allan Golston (Director), Kevin Lobo (CEO), Katherine Owen (VP), James Pierce (Insider), Bijoy Sagar (VP), Timothy Scannell (COO), and Ronda Stryker (Director). Learn More on Stryker's active insiders.

Are insiders buying or selling shares of Stryker?

In the last year, insiders at the medical technology company sold shares 10 times. They sold a total of 276,915 shares worth more than $91,507,152.07. The most recent insider tranaction occured on March, 7th when CAO William E Berry Jr sold 7,690 shares worth more than $2,756,711.20. Insiders at Stryker own 5.5% of the company. Learn More about insider trades at Stryker.

Information on this page was last updated on 3/7/2024.

Kevin A. Lobo Insider Trading History at Stryker

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/17/2023Sell56,483$287.91$16,262,020.5381,034View SEC Filing Icon  
12/2/2022Sell67,232$239.68$16,114,165.7680,770View SEC Filing Icon  
5/4/2021Sell107,795$255.79$27,572,883.05View SEC Filing Icon  
12/7/2020Sell10,697$236.28$2,527,487.16View SEC Filing Icon  
7/31/2020Sell25,855$190.80$4,933,134.00View SEC Filing Icon  
10/31/2019Sell19,286$215.71$4,160,183.06View SEC Filing Icon  
3/25/2019Sell41,750$194.11$8,104,092.50View SEC Filing Icon  
3/22/2018Sell39,808$162.90$6,484,723.20View SEC Filing Icon  
11/3/2016Sell26,306$115.74$3,044,656.44View SEC Filing Icon  
3/11/2016Sell25,952$105.00$2,724,960.0026,675View SEC Filing Icon  
See Full Table

Kevin A. Lobo Buying and Selling Activity at Stryker

This chart shows Kevin Lobo's buying and selling at Stryker by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Stryker Company Overview

Stryker logo
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Read More

Today's Range

Now: $337.54
Low: $334.20
High: $341.43

50 Day Range

MA: $350.75
Low: $338.79
High: $359.04

2 Week Range

Now: $337.54
Low: $249.98
High: $361.41

Volume

1,239,332 shs

Average Volume

1,254,691 shs

Market Capitalization

$128.42 billion

P/E Ratio

40.91

Dividend Yield

0.94%

Beta

0.89